Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Oncogene Proteins | 40 | 2018 | 765 | 7.070 |
Why?
|
Nuclear Proteins | 69 | 2022 | 6009 | 6.530 |
Why?
|
Oncogene Proteins, Fusion | 34 | 2020 | 1548 | 4.510 |
Why?
|
Carcinoma | 32 | 2022 | 2353 | 3.780 |
Why?
|
Carcinoma, Squamous Cell | 31 | 2021 | 3981 | 3.150 |
Why?
|
Neoplasm Proteins | 51 | 2022 | 3972 | 2.820 |
Why?
|
Cell Cycle Proteins | 22 | 2021 | 3471 | 1.790 |
Why?
|
Transcription Factors | 30 | 2022 | 11910 | 1.730 |
Why?
|
Gene Rearrangement | 24 | 2018 | 1210 | 1.700 |
Why?
|
E1A-Associated p300 Protein | 3 | 2020 | 131 | 1.530 |
Why?
|
Translocation, Genetic | 16 | 2018 | 1440 | 1.350 |
Why?
|
Mediastinal Neoplasms | 7 | 2016 | 450 | 1.330 |
Why?
|
In Situ Hybridization, Fluorescence | 23 | 2022 | 2628 | 1.270 |
Why?
|
Gene Fusion | 4 | 2022 | 356 | 1.030 |
Why?
|
Chromosomes, Human, Pair 15 | 8 | 2017 | 383 | 0.900 |
Why?
|
p300-CBP Transcription Factors | 2 | 2021 | 156 | 0.840 |
Why?
|
Chromosomes, Human, Pair 19 | 6 | 2017 | 378 | 0.820 |
Why?
|
Germ Cells | 2 | 2022 | 487 | 0.750 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2021 | 786 | 0.680 |
Why?
|
Chloride Channels | 1 | 2018 | 238 | 0.670 |
Why?
|
Adenocarcinoma, Follicular | 3 | 2016 | 292 | 0.600 |
Why?
|
Lung Neoplasms | 12 | 2022 | 12009 | 0.590 |
Why?
|
Pyridones | 1 | 2020 | 639 | 0.590 |
Why?
|
Acetanilides | 1 | 2016 | 166 | 0.560 |
Why?
|
Benzimidazoles | 1 | 2020 | 883 | 0.550 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2016 | 209 | 0.540 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2021 | 3557 | 0.530 |
Why?
|
Chromatin | 6 | 2021 | 2503 | 0.520 |
Why?
|
Proto-Oncogene Proteins c-myc | 3 | 2021 | 1042 | 0.500 |
Why?
|
Head and Neck Neoplasms | 3 | 2016 | 2606 | 0.500 |
Why?
|
Turbinates | 1 | 2013 | 68 | 0.490 |
Why?
|
Antineoplastic Agents | 6 | 2021 | 13898 | 0.490 |
Why?
|
Molecular Targeted Therapy | 4 | 2021 | 2884 | 0.490 |
Why?
|
Nasopharyngeal Neoplasms | 3 | 2011 | 267 | 0.480 |
Why?
|
Cell Line, Tumor | 14 | 2021 | 17251 | 0.470 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2020 | 8895 | 0.470 |
Why?
|
Tumor Suppressor Proteins | 3 | 2021 | 2902 | 0.460 |
Why?
|
Laryngeal Neoplasms | 6 | 2017 | 537 | 0.450 |
Why?
|
Small Molecule Libraries | 2 | 2020 | 739 | 0.440 |
Why?
|
Immunohistochemistry | 18 | 2022 | 12095 | 0.430 |
Why?
|
Sarcoma | 2 | 2018 | 1822 | 0.420 |
Why?
|
Maxillary Sinus Neoplasms | 3 | 2018 | 41 | 0.420 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2014 | 692 | 0.390 |
Why?
|
Neoplasms | 9 | 2021 | 19538 | 0.390 |
Why?
|
Testicular Neoplasms | 2 | 2021 | 730 | 0.380 |
Why?
|
Thyroid Neoplasms | 4 | 2018 | 2082 | 0.380 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2009 | 46 | 0.380 |
Why?
|
Cell Differentiation | 10 | 2018 | 11833 | 0.380 |
Why?
|
Digestive System Neoplasms | 1 | 2009 | 90 | 0.370 |
Why?
|
Nose Neoplasms | 4 | 2012 | 248 | 0.370 |
Why?
|
Otorhinolaryngologic Neoplasms | 1 | 2008 | 27 | 0.370 |
Why?
|
Sarcoma, Small Cell | 1 | 2007 | 18 | 0.360 |
Why?
|
SOXB1 Transcription Factors | 3 | 2021 | 301 | 0.340 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 2656 | 0.340 |
Why?
|
Humans | 95 | 2022 | 686663 | 0.310 |
Why?
|
Cytogenetic Analysis | 2 | 2012 | 300 | 0.310 |
Why?
|
Fatal Outcome | 7 | 2017 | 1939 | 0.310 |
Why?
|
Parotid Neoplasms | 3 | 2018 | 168 | 0.310 |
Why?
|
Rhinitis | 1 | 2013 | 620 | 0.310 |
Why?
|
Thymus Neoplasms | 2 | 2021 | 238 | 0.300 |
Why?
|
Repressor Proteins | 1 | 2017 | 3059 | 0.290 |
Why?
|
Sinusitis | 1 | 2013 | 823 | 0.280 |
Why?
|
PPAR gamma | 1 | 2008 | 500 | 0.280 |
Why?
|
Cell Proliferation | 5 | 2020 | 10990 | 0.270 |
Why?
|
RNA-Binding Proteins | 5 | 2016 | 1961 | 0.260 |
Why?
|
Female | 55 | 2022 | 375459 | 0.250 |
Why?
|
Adolescent | 27 | 2021 | 84957 | 0.250 |
Why?
|
Cell Nucleus | 5 | 2018 | 3092 | 0.250 |
Why?
|
Endoscopy | 1 | 2013 | 1688 | 0.250 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2011 | 1983 | 0.240 |
Why?
|
DNA-Binding Proteins | 3 | 2018 | 9934 | 0.220 |
Why?
|
Tumor Cells, Cultured | 4 | 2020 | 6835 | 0.220 |
Why?
|
Male | 52 | 2021 | 352465 | 0.210 |
Why?
|
Epithelial Cells | 2 | 2017 | 3715 | 0.210 |
Why?
|
Azepines | 2 | 2020 | 350 | 0.210 |
Why?
|
Adult | 39 | 2021 | 211400 | 0.200 |
Why?
|
Tracheal Neoplasms | 1 | 2020 | 125 | 0.200 |
Why?
|
Bone Neoplasms | 2 | 2014 | 2597 | 0.200 |
Why?
|
Child | 19 | 2021 | 71361 | 0.190 |
Why?
|
Paranasal Sinus Neoplasms | 2 | 2016 | 229 | 0.190 |
Why?
|
Thoracic Neoplasms | 2 | 2013 | 257 | 0.190 |
Why?
|
Abnormalities, Severe Teratoid | 1 | 1998 | 5 | 0.190 |
Why?
|
Middle Aged | 33 | 2021 | 216468 | 0.190 |
Why?
|
Sialoglycoproteins | 1 | 2020 | 384 | 0.190 |
Why?
|
Young Adult | 16 | 2021 | 56052 | 0.180 |
Why?
|
Lipoma | 1 | 2000 | 338 | 0.180 |
Why?
|
Aged | 25 | 2022 | 162271 | 0.180 |
Why?
|
RNA, Small Interfering | 3 | 2017 | 3713 | 0.180 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 858 | 0.180 |
Why?
|
Carcinoma, Papillary, Follicular | 1 | 2018 | 60 | 0.170 |
Why?
|
Pericardiocentesis | 1 | 2017 | 71 | 0.170 |
Why?
|
Fetal Diseases | 3 | 1998 | 860 | 0.170 |
Why?
|
Fetal Heart | 1 | 1998 | 265 | 0.160 |
Why?
|
Lymphoproliferative Disorders | 1 | 2000 | 542 | 0.160 |
Why?
|
Diagnosis, Differential | 7 | 2022 | 13603 | 0.160 |
Why?
|
Sublingual Gland Neoplasms | 1 | 2015 | 2 | 0.160 |
Why?
|
Femoral Neck Fractures | 1 | 2017 | 148 | 0.160 |
Why?
|
Histone Chaperones | 1 | 2016 | 69 | 0.160 |
Why?
|
Cardiac Tamponade | 1 | 2017 | 169 | 0.160 |
Why?
|
Tongue Neoplasms | 1 | 2017 | 188 | 0.160 |
Why?
|
Positron-Emission Tomography | 2 | 2017 | 5981 | 0.150 |
Why?
|
Child, Preschool | 11 | 2017 | 41159 | 0.150 |
Why?
|
Benzodiazepines | 1 | 2021 | 1040 | 0.150 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2016 | 380 | 0.150 |
Why?
|
Arcobacter | 1 | 2014 | 2 | 0.150 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1974 | 0.140 |
Why?
|
Proteins | 2 | 2021 | 6264 | 0.140 |
Why?
|
Adenocarcinoma | 3 | 2021 | 6450 | 0.140 |
Why?
|
Carcinoma, Basal Cell | 1 | 2019 | 499 | 0.140 |
Why?
|
Zinc Fingers | 1 | 2017 | 611 | 0.140 |
Why?
|
Adamantinoma | 1 | 2014 | 8 | 0.140 |
Why?
|
Acetylation | 3 | 2016 | 1140 | 0.140 |
Why?
|
Disease-Free Survival | 3 | 2016 | 7195 | 0.140 |
Why?
|
Histone Acetyltransferases | 1 | 2016 | 350 | 0.130 |
Why?
|
Mice, SCID | 1 | 2020 | 2913 | 0.130 |
Why?
|
Femoral Neoplasms | 1 | 2014 | 86 | 0.130 |
Why?
|
Histones | 2 | 2016 | 2566 | 0.130 |
Why?
|
Antigens, CD34 | 3 | 2011 | 672 | 0.130 |
Why?
|
Video Recording | 1 | 2018 | 958 | 0.130 |
Why?
|
Transfection | 2 | 2013 | 6329 | 0.120 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2018 | 761 | 0.120 |
Why?
|
Antibodies, Monoclonal | 3 | 2012 | 9863 | 0.120 |
Why?
|
Skin Neoplasms | 3 | 2019 | 5354 | 0.120 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 1154 | 0.120 |
Why?
|
Carcinoma, Papillary | 1 | 2018 | 809 | 0.120 |
Why?
|
Seminoma | 1 | 2013 | 123 | 0.120 |
Why?
|
Aged, 80 and over | 12 | 2021 | 59331 | 0.110 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2013 | 262 | 0.110 |
Why?
|
Neck | 1 | 2016 | 691 | 0.110 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2020 | 1252 | 0.110 |
Why?
|
Sleep Apnea Syndromes | 1 | 2018 | 841 | 0.110 |
Why?
|
Molecular Sequence Data | 7 | 2014 | 19328 | 0.110 |
Why?
|
Sarcoma, Endometrial Stromal | 1 | 2012 | 78 | 0.110 |
Why?
|
Azirines | 1 | 2010 | 31 | 0.110 |
Why?
|
Cell Cycle | 1 | 2020 | 3066 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3881 | 0.110 |
Why?
|
Dihydropyridines | 1 | 2010 | 63 | 0.110 |
Why?
|
Biopsy | 4 | 2018 | 6849 | 0.110 |
Why?
|
Predictive Value of Tests | 5 | 2022 | 15407 | 0.110 |
Why?
|
Nasal Cavity | 2 | 2009 | 301 | 0.110 |
Why?
|
Submandibular Gland Neoplasms | 1 | 2010 | 11 | 0.110 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2021 | 11115 | 0.110 |
Why?
|
14-3-3 Proteins | 1 | 2012 | 228 | 0.110 |
Why?
|
HEK293 Cells | 2 | 2017 | 4416 | 0.100 |
Why?
|
Paired Box Transcription Factors | 1 | 2011 | 228 | 0.100 |
Why?
|
Multiprotein Complexes | 1 | 2017 | 1178 | 0.100 |
Why?
|
Placenta | 1 | 1998 | 1353 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 4 | 2014 | 20409 | 0.100 |
Why?
|
Diagnostic Errors | 2 | 2016 | 1276 | 0.100 |
Why?
|
Thyroid Nodule | 1 | 2016 | 666 | 0.100 |
Why?
|
Protein Structure, Tertiary | 2 | 2015 | 4184 | 0.100 |
Why?
|
Flow Cytometry | 1 | 2000 | 6230 | 0.100 |
Why?
|
Treatment Outcome | 7 | 2021 | 60991 | 0.100 |
Why?
|
Thyroid Gland | 1 | 2016 | 1175 | 0.100 |
Why?
|
Combined Modality Therapy | 6 | 2017 | 9114 | 0.090 |
Why?
|
Phenotype | 3 | 2022 | 16091 | 0.090 |
Why?
|
Sequence Analysis, DNA | 2 | 2018 | 5044 | 0.090 |
Why?
|
Enhancer Elements, Genetic | 1 | 2015 | 1385 | 0.090 |
Why?
|
Anticonvulsants | 2 | 2018 | 1875 | 0.090 |
Why?
|
Antibody Specificity | 2 | 2009 | 1263 | 0.090 |
Why?
|
Karyotyping | 2 | 2008 | 1280 | 0.090 |
Why?
|
Drug Delivery Systems | 1 | 2020 | 2297 | 0.090 |
Why?
|
Hydroxamic Acids | 1 | 2011 | 496 | 0.090 |
Why?
|
Preoperative Care | 1 | 2017 | 2415 | 0.090 |
Why?
|
Mice | 5 | 2021 | 80803 | 0.090 |
Why?
|
Tibia | 1 | 2014 | 1036 | 0.090 |
Why?
|
RNA Interference | 1 | 2017 | 3103 | 0.080 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3337 | 0.080 |
Why?
|
Lymphatic Metastasis | 4 | 2018 | 3061 | 0.080 |
Why?
|
Cell Survival | 1 | 2018 | 6288 | 0.080 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2012 | 499 | 0.080 |
Why?
|
Orbital Neoplasms | 1 | 2009 | 249 | 0.080 |
Why?
|
Anesthetics, Local | 1 | 2014 | 993 | 0.080 |
Why?
|
Neoplasm Staging | 3 | 2016 | 11265 | 0.080 |
Why?
|
Infant | 4 | 2016 | 33918 | 0.080 |
Why?
|
Peptide Fragments | 1 | 2020 | 5167 | 0.080 |
Why?
|
Animals | 8 | 2021 | 170849 | 0.080 |
Why?
|
Mice, Nude | 2 | 2011 | 4040 | 0.080 |
Why?
|
Histone Deacetylases | 1 | 2011 | 727 | 0.080 |
Why?
|
Chromosome Aberrations | 2 | 2012 | 1799 | 0.080 |
Why?
|
Survival Rate | 2 | 2016 | 13606 | 0.080 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2014 | 3053 | 0.080 |
Why?
|
Infant, Newborn | 4 | 2016 | 23953 | 0.080 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1761 | 0.070 |
Why?
|
Aneuploidy | 2 | 2013 | 461 | 0.070 |
Why?
|
Soft Tissue Neoplasms | 1 | 2014 | 1310 | 0.070 |
Why?
|
Prognosis | 6 | 2017 | 28923 | 0.070 |
Why?
|
Heart Diseases | 1 | 2017 | 2671 | 0.070 |
Why?
|
Cytodiagnosis | 2 | 2016 | 413 | 0.070 |
Why?
|
DNA, Neoplasm | 3 | 2010 | 1867 | 0.070 |
Why?
|
Transplantation, Heterologous | 1 | 2011 | 2159 | 0.070 |
Why?
|
Precancerous Conditions | 1 | 2011 | 985 | 0.070 |
Why?
|
Epilepsy | 1 | 2018 | 2828 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 3 | 2022 | 17071 | 0.070 |
Why?
|
Electroencephalography | 1 | 2018 | 5579 | 0.070 |
Why?
|
Multigene Family | 1 | 2007 | 1200 | 0.060 |
Why?
|
Retrospective Studies | 7 | 2018 | 67320 | 0.060 |
Why?
|
Models, Molecular | 2 | 2014 | 5778 | 0.060 |
Why?
|
Apoptosis | 1 | 2020 | 10261 | 0.060 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2013 | 1885 | 0.060 |
Why?
|
Biopsy, Fine-Needle | 1 | 2008 | 1017 | 0.060 |
Why?
|
Expressed Sequence Tags | 1 | 2003 | 269 | 0.060 |
Why?
|
Rabbits | 1 | 2009 | 5339 | 0.060 |
Why?
|
DNA Methylation | 1 | 2016 | 3987 | 0.060 |
Why?
|
Remission Induction | 1 | 2007 | 2387 | 0.060 |
Why?
|
False Negative Reactions | 2 | 2020 | 617 | 0.060 |
Why?
|
Neoplasm Invasiveness | 3 | 2019 | 3789 | 0.060 |
Why?
|
alpha-Fetoproteins | 2 | 1994 | 203 | 0.060 |
Why?
|
Blotting, Southern | 1 | 2001 | 847 | 0.050 |
Why?
|
Seizures | 1 | 2013 | 2410 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 5114 | 0.050 |
Why?
|
Recombination, Genetic | 3 | 2018 | 1757 | 0.050 |
Why?
|
Keratins | 2 | 2013 | 557 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5252 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6970 | 0.050 |
Why?
|
HeLa Cells | 1 | 2007 | 3395 | 0.050 |
Why?
|
Mediastinum | 1 | 2021 | 264 | 0.050 |
Why?
|
S100 Proteins | 1 | 2000 | 275 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2016 | 4017 | 0.050 |
Why?
|
Amino Acid Sequence | 3 | 2014 | 14656 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2009 | 15075 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 3 | 2013 | 33186 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 3449 | 0.050 |
Why?
|
Testis | 1 | 2003 | 850 | 0.050 |
Why?
|
Chorion | 1 | 1998 | 114 | 0.050 |
Why?
|
Protein Binding | 4 | 2014 | 9947 | 0.050 |
Why?
|
Cyclin T | 1 | 2017 | 20 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2015 | 4648 | 0.040 |
Why?
|
Papillomavirus Infections | 1 | 2008 | 1371 | 0.040 |
Why?
|
Chronic Disease | 1 | 2013 | 8882 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 9 | 1 | 2017 | 77 | 0.040 |
Why?
|
Sequence Alignment | 2 | 2014 | 2352 | 0.040 |
Why?
|
Sarcoma, Synovial | 1 | 2018 | 175 | 0.040 |
Why?
|
Cerebrospinal Fluid | 1 | 2000 | 548 | 0.040 |
Why?
|
Amnion | 1 | 1998 | 194 | 0.040 |
Why?
|
Genes | 1 | 2001 | 1991 | 0.040 |
Why?
|
Immunoenzyme Techniques | 1 | 2000 | 1928 | 0.040 |
Why?
|
Brain Neoplasms | 2 | 2017 | 8590 | 0.040 |
Why?
|
Transcription, Genetic | 3 | 2017 | 8130 | 0.040 |
Why?
|
Twins, Monozygotic | 1 | 1998 | 447 | 0.040 |
Why?
|
Oncogenes | 1 | 2003 | 1212 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2001 | 1746 | 0.040 |
Why?
|
Base Sequence | 2 | 2007 | 13729 | 0.040 |
Why?
|
Fetal Death | 1 | 1998 | 458 | 0.040 |
Why?
|
Diseases in Twins | 1 | 1998 | 462 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2018 | 4415 | 0.040 |
Why?
|
Treatment Failure | 2 | 2014 | 2697 | 0.040 |
Why?
|
Alternative Splicing | 1 | 2001 | 1137 | 0.040 |
Why?
|
Histone Code | 1 | 2016 | 165 | 0.040 |
Why?
|
World Health Organization | 1 | 2021 | 1220 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2000 | 1915 | 0.040 |
Why?
|
Benzocaine | 1 | 2014 | 15 | 0.040 |
Why?
|
Prenatal Diagnosis | 2 | 1994 | 1081 | 0.040 |
Why?
|
Down Syndrome | 2 | 1994 | 727 | 0.040 |
Why?
|
Australia | 1 | 2017 | 1231 | 0.030 |
Why?
|
Echocardiography | 2 | 2017 | 5097 | 0.030 |
Why?
|
Molecular Mimicry | 1 | 1995 | 215 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2009 | 4064 | 0.030 |
Why?
|
Phenytoin | 1 | 2014 | 206 | 0.030 |
Why?
|
RNA Polymerase II | 1 | 2017 | 526 | 0.030 |
Why?
|
Antibodies, Antinuclear | 1 | 1995 | 336 | 0.030 |
Why?
|
Ifosfamide | 1 | 2013 | 227 | 0.030 |
Why?
|
SOXF Transcription Factors | 1 | 2013 | 31 | 0.030 |
Why?
|
Cough | 1 | 2017 | 537 | 0.030 |
Why?
|
Nucleosomes | 1 | 2016 | 459 | 0.030 |
Why?
|
Mutation | 1 | 2018 | 28848 | 0.030 |
Why?
|
Transcription Factor AP-2 | 1 | 2013 | 85 | 0.030 |
Why?
|
Binding Sites | 2 | 2014 | 6499 | 0.030 |
Why?
|
Thermodynamics | 1 | 2014 | 624 | 0.030 |
Why?
|
Genes, erbB-1 | 1 | 2013 | 170 | 0.030 |
Why?
|
Chorionic Gonadotropin | 1 | 1994 | 443 | 0.030 |
Why?
|
Membranes, Artificial | 1 | 2014 | 395 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2018 | 19308 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2009 | 5015 | 0.030 |
Why?
|
Etoposide | 1 | 2013 | 632 | 0.030 |
Why?
|
Polysomnography | 1 | 2018 | 1655 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2014 | 346 | 0.030 |
Why?
|
Consensus | 1 | 2021 | 2434 | 0.030 |
Why?
|
Blotting, Western | 2 | 2011 | 5678 | 0.030 |
Why?
|
Shock, Cardiogenic | 1 | 2017 | 592 | 0.030 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2013 | 245 | 0.030 |
Why?
|
Whole Body Imaging | 1 | 2014 | 274 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2016 | 39737 | 0.030 |
Why?
|
RNA-Binding Protein EWS | 1 | 2013 | 206 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2021 | 2944 | 0.030 |
Why?
|
Hospitals, Teaching | 1 | 2016 | 1163 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 934 | 0.030 |
Why?
|
Co-Repressor Proteins | 1 | 2012 | 186 | 0.030 |
Why?
|
Radiotherapy | 2 | 2009 | 1674 | 0.030 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2012 | 294 | 0.030 |
Why?
|
Fracture Fixation, Internal | 1 | 2017 | 819 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 2014 | 1281 | 0.030 |
Why?
|
Disease Progression | 3 | 2014 | 13204 | 0.030 |
Why?
|
Thyroidectomy | 1 | 2016 | 861 | 0.030 |
Why?
|
Genome, Human | 2 | 2016 | 4458 | 0.030 |
Why?
|
Extracellular Matrix Proteins | 1 | 1995 | 830 | 0.030 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2012 | 453 | 0.030 |
Why?
|
Submandibular Gland | 1 | 2010 | 95 | 0.030 |
Why?
|
Protein Subunits | 1 | 2014 | 1062 | 0.030 |
Why?
|
Autoantigens | 1 | 1995 | 914 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2012 | 783 | 0.030 |
Why?
|
Bacterial Translocation | 1 | 2009 | 81 | 0.030 |
Why?
|
Dyspnea | 1 | 2017 | 1210 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2010 | 709 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2011 | 594 | 0.020 |
Why?
|
Diplopia | 1 | 2009 | 179 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2013 | 798 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2012 | 2941 | 0.020 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2009 | 471 | 0.020 |
Why?
|
COS Cells | 1 | 2010 | 1261 | 0.020 |
Why?
|
Human papillomavirus 18 | 1 | 2008 | 122 | 0.020 |
Why?
|
Inpatients | 1 | 2018 | 2050 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2017 | 4807 | 0.020 |
Why?
|
Triazoles | 1 | 2014 | 931 | 0.020 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2009 | 554 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4716 | 0.020 |
Why?
|
Oral Surgical Procedures | 1 | 2009 | 163 | 0.020 |
Why?
|
Program Development | 1 | 1994 | 1334 | 0.020 |
Why?
|
Gene Expression | 2 | 2013 | 8182 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 11616 | 0.020 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2017 | 1336 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2014 | 1889 | 0.020 |
Why?
|
Cisplatin | 1 | 2013 | 1731 | 0.020 |
Why?
|
Human papillomavirus 16 | 1 | 2008 | 276 | 0.020 |
Why?
|
Mesoderm | 1 | 2009 | 749 | 0.020 |
Why?
|
Age of Onset | 1 | 2013 | 3373 | 0.020 |
Why?
|
Protein Transport | 1 | 2012 | 2101 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2018 | 6814 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 2 | 2010 | 3983 | 0.020 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2009 | 656 | 0.020 |
Why?
|
Pilot Projects | 1 | 2017 | 7791 | 0.020 |
Why?
|
Chromosomes, Human, 19-20 | 1 | 2003 | 13 | 0.020 |
Why?
|
Chromosomes, Human, 13-15 | 1 | 2003 | 54 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2008 | 2064 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2010 | 1885 | 0.020 |
Why?
|
Proteomics | 1 | 2016 | 3023 | 0.020 |
Why?
|
Radiography | 1 | 2015 | 7027 | 0.020 |
Why?
|
Membrane Proteins | 2 | 2012 | 8262 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 1995 | 2092 | 0.020 |
Why?
|
Laryngoscopy | 1 | 2008 | 683 | 0.020 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1995 | 1997 | 0.020 |
Why?
|
Boston | 1 | 2016 | 9534 | 0.020 |
Why?
|
Comorbidity | 1 | 2017 | 10648 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2013 | 2531 | 0.020 |
Why?
|
Prospective Studies | 3 | 2016 | 49071 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2010 | 2923 | 0.010 |
Why?
|
Cohort Studies | 2 | 2016 | 38732 | 0.010 |
Why?
|
Respiratory Tract Neoplasms | 1 | 2001 | 58 | 0.010 |
Why?
|
Epiglottis | 1 | 2001 | 75 | 0.010 |
Why?
|
Superior Vena Cava Syndrome | 1 | 2001 | 49 | 0.010 |
Why?
|
DNA, Viral | 1 | 2008 | 2341 | 0.010 |
Why?
|
Pregnancy | 3 | 1998 | 25703 | 0.010 |
Why?
|
DNA | 1 | 1995 | 7320 | 0.010 |
Why?
|
Computer Simulation | 1 | 2014 | 6120 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2010 | 7060 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2010 | 2912 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6464 | 0.010 |
Why?
|
Quality of Life | 1 | 2018 | 10676 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2013 | 13469 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2003 | 19153 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 23739 | 0.010 |
Why?
|
Binding Sites, Antibody | 1 | 1995 | 397 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9661 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2017 | 15083 | 0.010 |
Why?
|
Incidence | 1 | 2012 | 20496 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 1995 | 296 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 1995 | 1026 | 0.010 |
Why?
|
Chromosome Disorders | 1 | 1994 | 481 | 0.010 |
Why?
|
False Positive Reactions | 1 | 1994 | 1030 | 0.010 |
Why?
|
Pregnancy Trimester, Second | 1 | 1994 | 707 | 0.010 |
Why?
|
Maternal Age | 1 | 1994 | 795 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 1995 | 2009 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1995 | 1858 | 0.010 |
Why?
|
United States | 1 | 2018 | 65579 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1988 | 979 | 0.010 |
Why?
|
Ultrasonography, Prenatal | 1 | 1994 | 1531 | 0.000 |
Why?
|
Gestational Age | 1 | 1994 | 3308 | 0.000 |
Why?
|
Genetic Testing | 1 | 1994 | 3230 | 0.000 |
Why?
|
Risk Factors | 1 | 1994 | 69278 | 0.000 |
Why?
|